LITS on Nasdaq

Lite Strategy, Inc.

American pharmaceutical preparations company, incorporated in Delaware. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

-$71.2MNet income, fiscal 20262

Compare with ENANTA PHARMACEUTICALS INC, Fortress Biotech or Zentalis Pharmaceuticals, Inc., or pick any stock.

  • TickerLITS on Nasdaq1
  • IndustryPharmaceutical Preparations1
  • HeadquartersSan Diego, California1
  • Incorporated inDE3
  • Business address9920 Pacific Heights Blvd, Suite 150, San Diego, Ca 921213
  • Filer categoryNon-accelerated filer, Smaller reporting company3

See how the biggest companies compare on our leaderboards

Lite Strategy, Inc. (Nasdaq: LITS) is a pharmaceutical company that has historically developed novel and differentiated cancer therapies. During fiscal year 2026, we commenced pre-clinical development programs in nononcologic disease indications. We also hold Litecoin (LTC) tokens as a primary reserve asset as part of our broader institutional treasury initiative. We initially built our pipeline by acquiring promising cancer agents and creating value in programs through clinical development, strategic partnerships, and out-licensing or commercialization, as appropriate. Our approach to pre-clinical drug development is to evaluate our drug candidates either as stand-alone or in combination with standard-of-care therapies to overcome known resistance mechanisms and address medical needs to provide improved patient benefit. Our drug candidate pipeline includes voruciclib, an oral cyclin-dep…4 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

-100.0%Revenue growth, 20255
-94.2%Return on equity2
-$20.8MFree cash flow2

Financial statements

Revenue67895$0 in 2025
0$20.0M$40.0M$60.0M$80.0M2019: $4.9M$4.9M20192020: $27.8M$27.8M2020+465%2021: $34.8M$34.8M2021+25%2022: $40.7M$40.7M2022+17%2023: $48.8M$48.8M2023+20%2024: $65.3M$65.3M2024+34%2025: $0$02025
Operating income678952-$17.5M in 2025−62% since 2019
-$100.0M-$75.0M-$50.0M-$25.0M0$25.0M2019: -$46.2M-$46.2M20192020: -$25.7M-$25.7M2020−44%2021: -$60.4M-$60.4M2021+135%2022: -$75.5M-$75.5M2022+25%2023: -$36.8M-$36.8M2023−51%2024: $14.5M$14.5M20242025: -$17.5M-$17.5M2025
Net income671052-$15.9M in 2025−5% since 2019
-$60.0M-$40.0M-$20.0M0$20.0M2019: -$16.8M-$16.8M20192020: -$47.2M-$47.2M2020+180%2021: -$41.0M-$41.0M2021−13%2022: -$54.0M-$54.0M2022+32%2023: -$32.0M-$32.0M2023−41%2024: $18.0M$18.0M20242025: -$15.9M-$15.9M2025

Every line of the income statement as filed: the last 3 fiscal years, latest first.2

Period ending2026-06-302025-06-302024-06-30
Research and development$122.0K$3.9M
General and administrative$12.0M$13.5M
Change in fair value of digital assets$54.4M$0
Total operating expenses$66.6M$17.5M
Loss from operations-$66.6M-$17.5M
Change in fair value of digital assets receivable, net-$5.7M$0
Gain on derivative liabilities, net$813.0K$0
Interest and dividend income$267.0K$1.0M
Gain on disposition of a nonfinancial asset$0$500.0K
Other expense, net$0-$16.0K
Total other (expense) income, net-$4.6M$1.5M
Net loss-$71.2M-$15.9M$18.0M
Basic-$2.06-$2.39
Diluted-$2.06-$2.39
Basic34.6M shares6.7M shares
Diluted34.6M shares6.7M shares

Compare Lite Strategy, Inc. with another company

Leadership

Who has led Lite Strategy, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Christopher Naughton2008
  2. Daniel P. Gold Phd.2010–2022
  3. David M. Urso2023

President

  1. Christopher Naughton2008
  2. Daniel P. Gold Phd.2010
  3. David M. Urso2023

Chief financial officer

  1. Thomas M. Zech2010–2016
  2. Brian G. Drazba2017–2022

Chief operating officer

  1. David M. Urso2018–2022
2010201520202025
Board members and other officers (22)

Former names

  • MEI Pharma, Inc.Jul 2, 2012 to Sep 10, 20253
  • MARSHALL EDWARDS INCSep 25, 2003 to Jun 6, 20123

Timeline

  1. Jun 6, 2023New chief executive David M. Urso becomes CEO15
  2. May 4, 2010New chief executive Daniel P. Gold Phd. becomes CEO16
  3. Mar 17, 2008New chief executive Christopher Naughton becomes CEO17

Filings

290 filings to the SEC since October 2021: 7 annual reports, 17 quarterly reports, 76 major events, 67 insider forms, 30 large holders, 93 other. The latest 20:

  1. Oct 6, 2026EFFECT EDGAR
  2. Sep 28, 2026S-8 EDGAR
  3. Sep 28, 2026S-3 EDGAR
  4. Sep 28, 202610-K EDGAR
  5. Aug 3, 2026SCHEDULE 13G/A EDGAR
  6. Jul 30, 20268-K EDGAR
  7. Jul 24, 20268-K EDGAR
  8. Jun 25, 20264 EDGAR
  9. May 13, 20268-K EDGAR
  10. May 13, 202610-Q EDGAR
  11. Feb 17, 20268-K EDGAR
  12. Feb 17, 202610-Q EDGAR
  13. Feb 17, 2026SCHEDULE 13G/A EDGAR
  14. Feb 12, 20264 EDGAR
  15. Feb 12, 20268-K EDGAR
  16. Jan 27, 2026DEFA14A EDGAR
  17. Dec 30, 2025ARS EDGAR
  18. Dec 30, 2025DEFA14A EDGAR
  19. Dec 30, 2025DEF 14A EDGAR
  20. Dec 30, 20258-K EDGAR

The 290 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

11 open-market trades by officers, directors and large owners since October 2021: 10 buys and 1 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jun 24, 2026Flynn James PDirectorBuy25,000$0.86$21.5KForm 4
Dec 19, 2025Flynn James PDirectorBuy70,000$1.40$98.0KForm 4
Dec 18, 2025Schornstein Alexander10% ownerSale690,611$1.37$946.1KForm 4
Nov 19, 2025Flynn James PDirectorBuy12,100$1.88$22.7KForm 4
Sep 22, 2023Winson Bruce Ross10% ownerBuy48,060$6.85$329.2KForm 4
Sep 22, 2023Ma-Weaver Jacob10% ownerBuy32,040$6.85$219.5KForm 4
Sep 21, 2023Kassam Moez10% ownerBuy33,600$6.46$217.1KForm 4
Sep 21, 2023Ma-Weaver Jacob10% ownerBuy22,400$6.46$144.7KForm 4
Sep 20, 2023Kassam Moez10% ownerBuy120,000$6.01$721.2KForm 4
Sep 20, 2023Ma-Weaver Jacob10% ownerBuy80,000$6.01$480.8KForm 4
Feb 28, 2023Baltic Charles V. IIIDirectorBuy81,500$0.23$18.7KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 35. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Renaissance Technologies LLC1,247,350$1.2M0.0%−497,350
Vanguard Capital Management LLC1,021,892$942.2K0.0%−21,421
RLH Capital LLC806,433$743.9K0.4%New
Two Sigma Investments, LP557,011$513.8K0.0%−57,431
Geode Capital Management, LLC365,019$337.1K0.0%−36,072
Citadel Advisors LLC357,529$329.8K0.0%−372,570
BlackRock, Inc.275,829$254.4K0.0%+117,938
Marshall Wace, Llp232,979$214.3K0.0%−100,529
Vanguard Fiduciary Trust Co195,392$180.2K0.0%+1,397
Jane Street Group, LLC192,627$177.7K0.0%+135,381
State Street Corp115,021$106.1K0.0%No change
UBS Group AG91,141$84.0K0.0%+39,791
Northern Trust Corp75,497$69.6K0.0%−4,734
Morgan Stanley71,408$65.9K0.0%+50
XTX Topco Ltd68,165$62.9K0.0%−67,859
ADAR1 Capital Management, LLC67,292$62.1K0.0%No change
Nomura Asset Management International Inc.29,999$28.0K0.0%No change
Vanguard Global Advisers, LLC17,937$16.5K0.0%No change
Susquehanna International Group, Llp15,821$14.6K0.0%−313
Two Sigma Securities, LLC13,986$12.9K0.0%New
Group One Trading LLC2,598$2.4K0.0%−20,541
NFSG Corp1,999$1.8K0.0%No change
Barclays PLC532$4910.0%New
Bnp Paribas Financial Markets462$4260.0%No change
HighMark Wealth Management LLC287$2640.0%No change

13F reports cover disclosed long positions in U.S. stocks only.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49